53. Which of the following is NOT an adverse effect of sulfonylureas?
Anonymous Quiz
11%
a. Hypoglycemia
11%
b. Hyperinsulinemia
10%
c. Weight gain
42%
d. Hyperlipidemia
27%
e. Allergic reactions
54. What risk is associated specifically with glyburide in the context of renal impairment?
Anonymous Quiz
8%
a. Increased risk of hyperglycemia
67%
b. Increased risk of hypoglycemia
7%
c. Increased risk of allergic reactions
9%
d. Increased risk of hyperinsulinemia
8%
e. No specific risks related to renal impairment
55. Which of the following conditions should be used with caution when prescribing sulfonylureas?
Anonymous Quiz
36%
a. Hepatic insufficiency
55%
b. Renal insufficiency
5%
c. Cardiovascular disease
3%
d. Respiratory conditions
1%
e. Gastrointestinal disorders
56.How do sulfonylureas differ from metformin in terms of their mechanism of action?
Anonymous Quiz
15%
a. Sulfonylureas inhibit hepatic glucose production, while metformin stimulates insulin release.
59%
b. Sulfonylureas promote insulin release, while metformin inhibits hepatic glucose production.
16%
c. Both sulfonylureas and metformin inhibit hepatic glucose production.
8%
d. Both sulfonylureas and metformin promote insulin release.
3%
e. Sulfonylureas have no effect on glucose metabolism.
57. What effect do sulfonylureas have on ATP-sensitive K+ channels in pancreatic β cells?
Anonymous Quiz
3%
a. Activation
7%
b. Inhibition
86%
c. Blockade
2%
d. Sensitization
2%
e. None of the above
✨طريقك نحو الرسوب✨
56.How do sulfonylureas differ from metformin in terms of their mechanism of action?
هو كاتب differ ليش مختارين C؟
58. What is the primary outcome of blocking ATP-sensitive K+ channels in pancreatic β cells by sulfonylureas?
Anonymous Quiz
4%
a. Hyperglycemia
3%
b. Insulin sensitization
87%
c. Depolarization
6%
d. Increased hepatic glucose production
0%
e. Glucagon release
59. How are sulfonylureas typically administered?
Anonymous Quiz
3%
a. Intravenously
60%
b. Orally
35%
c. Subcutaneously
1%
d. Intramuscularly
1%
e. Through inhalation
60. What is a potential adverse effect specifically associated with glyburide in patients with renal impairment?
Anonymous Quiz
9%
a. Hyperglycemia
80%
b. Hypoglycemia
6%
c. Weight gain
3%
d. Allergic reactions
2%
e. Liver dysfunction
❤1
راح انشرلكم الملفات ، أول 3 ملفات (لكجر1،2،3،4) ، حل الدكتور👇🏻
*اكو بعض التعديلات نشرتهم بالقناة فَ بكيفكم منو تعتمدون🤍
*اكو بعض التعديلات نشرتهم بالقناة فَ بكيفكم منو تعتمدون🤍
👏5
MCQs Pharma. , Lec5.pdf
560.5 KB
هذه حلول لكجر 5 .
إلّي بالاصفر هذا الحل من الملزمة نصًا✅
بالاحمر ، حل الدكتور✅
واكو كم نقطة بدون حل من نتأكد ننشرهم✅
تعديل : حل الدكتور للنقاط إلّي ممحلولة👇🏻
17. C
39. b
40. d
إلّي بالاصفر هذا الحل من الملزمة نصًا✅
بالاحمر ، حل الدكتور✅
واكو كم نقطة بدون حل من نتأكد ننشرهم✅
تعديل : حل الدكتور للنقاط إلّي ممحلولة👇🏻
17. C
39. b
40. d
🙏2❤1
✨طريقك نحو الرسوب✨
MCQs Pharma. , Lec5.pdf
وإذا عدكم مشكلة بحل لكجر 5 دزوا إلنا و نوضح الكم ، وهسة نروح نفطر ، نرجع بعد الفطور🏃🏻♀️🏃🏻♀️
❤🔥2
❇Response to methotrexate occurs within 3 to 6 weeks
❇Hydroxychloroquine :onset of effects takes 6 weeks to 6 months.
❇Sulfasalazine :Onset of activity is 1 to 3 month
❇Etanercept is given subcutaneously once weekly
❇Adalimumab is administered subcutaneously weekly
❇Infliximab is administered as an IV infusion every 8 weeks.
❇ Rituximab is administered
as an intravenous infusion every 16 to 24 weeks
❇tocilizumab and sarilumab are administered as a subcutaneous injection every 2 weeks
❇Tocilizumab may also be administered as an intravenous
infusion every 4 weeks.
❇Hydroxychloroquine :onset of effects takes 6 weeks to 6 months.
❇Sulfasalazine :Onset of activity is 1 to 3 month
❇Etanercept is given subcutaneously once weekly
❇Adalimumab is administered subcutaneously weekly
❇Infliximab is administered as an IV infusion every 8 weeks.
❇ Rituximab is administered
as an intravenous infusion every 16 to 24 weeks
❇tocilizumab and sarilumab are administered as a subcutaneous injection every 2 weeks
❇Tocilizumab may also be administered as an intravenous
infusion every 4 weeks.
🙏2